general

Catalyst Clinic Reviewed: Compounded GLP-1 Pricing, Protocol, and What's Missing

June 4, 2026

Catalyst Clinic Reviewed: Compounded GLP-1 Pricing, Protocol, and What's Missing

The Catalyst Clinic: What You're Actually Getting When You Sign Up

You've done the research, shortlisted a few providers, and Catalyst Clinic keeps coming up — on Reddit threads, in GLP-1 comparison forums, occasionally in sponsored placements that are easy to miss as ads. The name sounds authoritative. The site is clean. The pricing looks competitive. But "looks competitive" is exactly the kind of phrase that deserves a harder look before you hand over a credit card and start waiting for a shipment.

Here's what the evidence actually shows about how Catalyst Clinic positions itself, what's typical for this tier of telehealth provider, and where the gaps tend to appear.


What Catalyst Clinic Is Selling

Catalyst Clinic operates in the compounded GLP-1 space — primarily semaglutide and tirzepatide formulations prepared by third-party 503B or 503A compounding pharmacies rather than the branded manufacturers (Novo Nordisk and Eli Lilly, respectively). This is a legitimate model. The FDA temporarily permitted compounding of these drugs during shortage periods, and the FDA's updated guidance issued in late 2025 significantly narrowed which compounders can still legally produce semaglutide, affecting every clinic in this category.

Catalyst's pricing as of June 2026 sits in the $199–$299/month range for semaglutide, depending on dose and plan tier — consistent with the broader mid-market compounded GLP-1 segment, which typically runs $150–$350/month. That's a meaningful discount against branded Wegovy's list price of approximately $1,350/month without insurance, though most patients with commercial coverage pay considerably less.


The Protocol: Standard or Differentiated?

Most compounded GLP-1 programs follow a nearly identical titration structure: starting at 0.25 mg/week of semaglutide for four weeks, stepping up to 0.5 mg, then 1.0 mg, then to maintenance doses up to 2.4 mg/week — mirroring the STEP 1 trial protocol (Wilding et al., 2021, NEJM, n=1,961) that demonstrated 14.9% mean body weight reduction over 68 weeks.

Catalyst's published protocol doesn't deviate from this structure. What matters more in practice is what happens when you hit a plateau, have a side effect at week six, or need a dose adjustment that doesn't fit neatly into the standard ladder. Some programs offer responsive clinical support; others route you through a ticketing system with 48–72 hour response windows. Catalyst's model leans toward asynchronous messaging with a provider, which is adequate for routine check-ins but consistently falls short during the first three months, when nausea, fatigue, and appetite fluctuations are most unpredictable and patients most frequently need real-time guidance.


Compounding Quality: The Part Nobody Advertises

The compounding pharmacy behind any clinic is the most important variable most patients never investigate. Catalyst, like most telehealth GLP-1 platforms, does not prominently display which pharmacy compounds their peptides — a pattern common across the industry.

Ask directly. A reputable clinic operating within current FDA guidelines should be able to tell you whether their pharmacy is a 503B outsourcing facility (subject to FDA inspection, cGMP manufacturing standards) or a 503A retail pharmacy (patient-specific compounding, state-regulated). The quality controls are materially different. One reliable proxy: 503B facilities appear on the FDA's registered outsourcing facility list, which is publicly searchable at fda.gov. If a clinic can't or won't name their compounder, that's a gap worth taking seriously before you start injecting.

If you want a broader view of how Catalyst stacks up structurally against other programs, the compare GLP-1 providers tool breaks down pharmacy sourcing transparency, response time claims, and contract flexibility across the main platforms in this market.


What the Pricing Actually Includes

The $199–$299/month number deserves unpacking. Catalyst's entry tier covers the medication, the initial provider consultation, and messaging access. What it doesn't include: ongoing lab monitoring, which standard GLP-1 protocols recommend at baseline and again at the three-month mark. Standard panels — fasting glucose, HbA1c, lipids, and a basic metabolic panel — run $80–$150 out of pocket without insurance. Some programs, including Ro Body and Found, bundle labs into their monthly fee; Catalyst does not as a default.

There's also the question of what happens when you need to titrate faster or slower than the standard protocol allows. Customised dosing adjustments sometimes trigger additional consultation fees. Cancellation policies matter here — some programs lock you into three-month prepayment structures that aren't prominently disclosed at signup.

For a side-by-side comparison of what's actually bundled at different price points, the best online GLP-1 programs page is a cleaner reference than trying to parse individual clinic FAQs.


Who Catalyst Is Probably Right For

A patient who has used GLP-1s before, knows their ideal starting dose, doesn't need close guidance through the titration curve, and wants a lower monthly cost than branded alternatives — Catalyst is a reasonable option for that profile. The clinical oversight is thin but present, and the pricing is honest about being a budget-tier model.

Where it fits less well: first-time GLP-1 users with significant metabolic complexity (Type 2 diabetes, thyroid conditions, history of pancreatitis), patients who want frequent synchronous provider contact, or anyone who needs flexibility in protocol design. Those patients are better served by clinics offering more substantive monitoring infrastructure — which you can filter for directly in the clinics directory if you're open to comparing alternatives.


The Honest Takeaway

Catalyst Clinic is a functional mid-market telehealth platform — neither the cheapest option in the compounded GLP-1 space nor the most clinically robust. Its main appeal is accessibility and price. Its main liability is the same as most providers at this tier: no disclosed pharmacy name on the website, no bundled lab monitoring, and asynchronous-only provider access. Before signing up, get the pharmacy name in writing, confirm 503B status on the FDA's outsourcing facility list, and clarify whether lab work is included or billed separately. Those three questions will tell you more about what you're actually buying than the homepage ever will.

Peptide Clinic Finder is a comparison platform. The author may receive compensation if you sign up through links on our partner pages.


Compare Providers